Anti-SARS-COV-2-S1RBD Antibody
Product Description
Specifications
| Size | 20 µg, 100 µg, 200 µg, 500 µg |
|---|---|
| Species | SARS-CoV-2 |
| Host Species | Mouse |
| Accession Number | QHD43416 |
| Protein Name / Synonyms | SARS-CoV-2 S1RBD |
| Clonality | Monoclonal |
| Clone | 1H9-G1-A1 |
| Immunogen | Immunogen was recombinant SARS-CoV-2, S1 Subunit Protein (RBD) with C-terminal His tag, derived from the transfected human HEK293 cells. This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with the immunogen. The IgG fraction of tissue culture supernatant was purified by Protein G/A affinity chromatography. |
| Specificity | 81% cross-reactivity with N501Y, 61% cross-reactivity with E484K, and 4% cross-reactivity with E484K-N501Y-K417N. |
| Recommended Applications | ELISA (recommended work dilution = 1:320,000) Neutralization was measured by ability to inhibit entry of pseudovirus harboring the SARS-CoV-2 spike protein into A549 cells. This antibody was also demonstrated to block S1 RBD-ACE2 binding in vitro. |
| Reconstitution | Product is supplied as a powder obtained from lyophilization of purified antibody in 1 x PBS. Reconstitute the antibody with sterile water to a final concentration of 1 mg/ml. |
| Estimated Lead Time | 1-2 business days |
| Shipping Type | Ambient temperature |
| Storage | -20°C |
Related Products
Check items to add to the cart or
